Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma. Howarth P, Quirce S, Papi A, Israel E, et al. Allergy 2020 Mar 9. doi: 10.1111/all.14266.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Howarth P, Quirce S, Papi A, Israel E, et al. Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma. Allergy 2020 Mar 9. doi: 10.1111/all.14266.
PMID: 32147844